Page results
-
UCH Chemotherapy Daycare and the Macmillan Support and Information Service are shortlisted for a Patient Experience Network National Award for the use of data from the Cancer Patient Experience Survey to improve patient experience.
-
The world’s first COVID-19 vaccine study researching alternating doses and intervals of approved vaccines is taking place at UCLH.
-
Three patients in the UK have received an innovative treatment for the most serious form of lupus – an autoimmune condition which can cause damage to the heart, lungs, joints, brain or kidneys.
-
In a major study involving UCLH a third of people who took a new drug for treating obesity lost more than one-fifth of their total body weight.
-
UCLH has continued to achieve excellent results in the National Inpatient Survey, with patients rating their overall care as 8.7 out of 10 – the top score amongst our London peers.
-
This page has been written for parents, carers and family members who are acting as carers and comforters for children and young people having radioactive mIBG treatment.
-
You now need a registered site administrator to access EpicCare Link UCLH for your practice or service. If your site doesn’t have a registered administrator, you may lose access to EpicCare Link UCLH.
-
This easy read page offers advice for patients on managing pain after an operation.
-
When Sam Ahern was born 24 years ago, she was the smallest baby our neonatal unit had ever looked after. Now an accomplished musician and fine art student, she has gone back to meet the team that helped her win her fight for life.
-
A new CAR T-cell therapy developed by scientists at UCL has fewer ‘toxic’ side-effects and is more durable, targeting and killing cancer cells for longer, concludes a Phase 1 clinical trial of patients at UCLH.
File results
-
FOI201769 A&E attendances by patients with mental health related issues
-
Charity Matters magazine - Winter 2020
-
FOI201771 Cataract and glaucoma operations
-
FOI201774 Maternity services
-
FOI201776 Serious incidents and deaths of patients with a learning disability
-
FOI/2023/0275 - Trust statistics on spiking
-
FOI/2023/0262 - Clinical trial participation
-
FOI/2023/0332 - Eating disorder services and Advance Decisions/ Directives to refuse medical treatment (ADRTs)
-
FOI/2023/0260 - Treatment for rare diseases: Fabry, Gaucher and Pompe disease and Hunter Syndrome
-
FOI/2023/0226 - Treatment with Nivolumab